Aastrom Biosciences' CEO to Present at the UBS Global Life Sciences Conference Ann Arbor, Michigan, September 23, 2005 -- Aastrom Biosciences, Inc. (Nasdaq: ASTM) today announced that R. Douglas Armstrong, Ph.D., Chief Executive Officer and Chairman, will present at the UBS Global Life Sciences

Aastrom Biosciences, Inc. Reports Fourth Quarter 2005 Financial Results Ann Arbor, Michigan, September 8, 2005 -- Aastrom Biosciences, Inc. (Nasdaq: ASTM) today reported financial results for the fourth quarter and fiscal year ended June 30, 2005.  The Company also reported significant clinical and

Aastrom Announces Its Fourth Quarter and Fiscal Year End Investor Conference Call Ann Arbor, MI, September 7 -- Aastrom Biosciences (NASDAQ: ASTM) announces the following Webcast: What: Aastrom Biosciences Fourth Quarter and Fiscal Year End FY2005 Investor Conference Call When: Thursday, September

-- Phase II Grant to Support Bone Formation and Vascularization Capabilities of Company's Tissue Repair Cells --

Stephen G. Sudovar Elected to Aastrom Biosciences' Board of Directors Ann Arbor, Michigan, August 2, 2005 -- Aastrom Biosciences, Inc. (Nasdaq: ASTM) announced today that Stephen G. Sudovar, former President and CEO of EluSys Therapeutics, Inc. and former President of Roche Laboratories, Inc., has

-- UNMC is 5th Site Open to Patient Enrollment for the Repair of Severe Leg Fractures Using Aastrom's Proprietary TRCs --

Aastrom Biosciences, Inc. Added to Russell 3000 Index Ann Arbor, Michigan, June 28, 2005 - Aastrom Biosciences, Inc. (Nasdaq: ASTM) announced today that it was added to the Russell 3000® Index effective at the close of market on Friday, June 24, 2005.

Timothy M. Mayleben Elected to Aastrom Biosciences' Board of Directors Ann Arbor, Michigan, June 22, 2005 -- Aastrom Biosciences, Inc. (Nasdaq: ASTM) announced today that Timothy M. Mayleben has been elected to the Company's Board of Directors. Mr. Mayleben's election became effective June 20, 2005

-- Appointment of Gerald D. Brennan, Jr., JD, Effective July 2, 2005 --

Aastrom Biosciences' CEO to Present at the Morgan Stanley Small Cap Executive Conference Ann Arbor, Michigan, June 10, 2005 -- Aastrom Biosciences, Inc. (Nasdaq: ASTM) today announced that R. Douglas Armstrong, Ph.D., Chief Executive Officer and Chairman, will present at the Morgan Stanley Small